Evidence for Involvement of ADP-Ribosylation Factor 6 in Intracellular Trafficking and Release of Murine Leukemia Virus Gag
Cells · 2024
DOI: 10.3390/cells13030270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Hyokyun Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Savannah State University, Savannah, GA 31404, USA. Hauptthemen laut MEDLINE: ADP-Ribosylation Factor 6, Leukemia Virus, Murine, Viral Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, HBCU-UP RIA.
Abstract (Originalsprache)
Murine leukemia viruses (MuLVs) are simple retroviruses that cause several diseases in mice. Retroviruses encode three basic genes: gag, pol, and env. Gag is translated as a polyprotein and moves to assembly sites where viral particles are shaped by cleavage of poly-Gag. Viral release depends on the intracellular trafficking of viral proteins, which is determined by both viral and cellular factors. ADP-ribosylation factor 6 (Arf6) is a small GTPase that regulates vesicular trafficking and recycling of different types of cargo in cells. Arf6 also activates phospholipase D (PLD) and phosphatidylinositol-4-phosphate 5-kinase (PIP5K) and produces phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2). We investigated how Arf6 affected MuLV release with a constitutively active form of Arf6, Arf6Q67L. Expression of Arf6Q67L impaired Gag release by accumulating Gag at PI(4,5)P2-enriched compartments in the cytoplasm. Treatment of the inhibitors for PLD and PIP5K impaired or recovered MuLV Gag release in the cells expressing GFP (control) and Arf6Q67L, implying that regulation of PI(4,5)P2 through PLD and PIP5K affected MuLV release. Interference with the phosphoinositide 3-kinases, mammalian target of rapamycin (mTOR) pathway, and vacuolar-type ATPase activities showed further impairment of Gag release from the cells expressing Arf6Q67L. In contrast, mTOR inhibition increased Gag release in the control cells. The proteasome inhibitors reduced viral release in the cells regardless of Arf6Q67L expression. These data outline the differences in MuLV release under the controlled and overactivated Arf6 conditions and provide new insight into pathways for MuLV release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Savannah State University, Savannah, GA 31404, USA.
- Department of Molecular Biology and Biochemistry, Cancer Research Institute, University of California, Irvine, CA 92697, USA.
ORCID-Profile: Takayuki Nitta
Förderung
- NIGMS NIH HHS
- NIH HHS
- HBCU-UP RIA
- Equipment/Instrumentation
- NIH MARC-U
- HBCU/MI Basic Research
Zitieren
APA
Kang, H., Kang, T., Jackson, L., Murphy, A., & Nitta, T. (2024). Evidence for Involvement of ADP-Ribosylation Factor 6 in Intracellular Trafficking and Release of Murine Leukemia Virus Gag. Cells. https://doi.org/10.3390/cells13030270
Vancouver
Kang H, Kang T, Jackson L, Murphy A, Nitta T. Evidence for Involvement of ADP-Ribosylation Factor 6 in Intracellular Trafficking and Release of Murine Leukemia Virus Gag. Cells. 2024. doi:10.3390/cells13030270
BibTeX
@article{Kang2024,
author = {Kang, Hyokyun and Kang, Taekwon and Jackson, Lauryn and Murphy, Amaiya and Nitta, Takayuki},
title = {Evidence for Involvement of ADP-Ribosylation Factor 6 in Intracellular Trafficking and Release of Murine Leukemia Virus Gag},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13030270}
}
EUVIMED